World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
57590
World Ranking
7510
National Ranking
3921

Ross S. Berkowitz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ross S. Berkowitz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 644 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ross S. Berkowitz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ross S. Berkowitz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ross S. Berkowitz is affiliated with Harvard Medical School in the United States. Their research primarily focuses on medicine, with particular emphasis on public health, environmental and occupational health, pediatrics, perinatology, child health, surgery, reproductive medicine, and oncology. The scientist's work covers important topics such as gestational trophoblastic disease studies, prenatal screening and diagnostics, ectopic pregnancy diagnosis and management, ovarian cancer diagnosis and treatment, congenital diaphragmatic hernia studies, maternal and fetal healthcare, and intraperitoneal and appendiceal malignancies.

Berkowitz has published extensively in several academic venues. Frequent publication venues include:

  • Gynecologic Oncology
  • International Journal of Gynecological Cancer
  • Hematology/Oncology Clinics of North America
  • Clinics
  • The Lancet Oncology

The scientist's recent papers illustrate their involvement in reproductive and oncological conditions. Selected recent papers include:

  • "Diagnosis and management of gestational trophoblastic disease: 2021 update" (2021), International Journal of Gynecology & Obstetrics
  • "Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer" (2020), Cancer Research
  • "Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study" (2020), Gynecologic Oncology
  • "Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study" (2021), The Lancet Oncology
  • "Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease" (2021), Best Practice & Research Clinical Obstetrics & Gynaecology

Berkowitz frequently collaborates with other researchers. Key collaborators include Neil S. Horowitz, Kevin M. Elias, Antônio Braga, Izildinha Maestá, and Michael J. Worley. The number of joint publications with these colleagues ranges from 13 to 69, indicating ongoing cooperative research efforts.

Best Publications

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

    R C Bast;T L Klug;E St John;E Jenison

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

    David W. Kindelberger;Yonghee Lee;Alexander Miron;Michelle S. Hirsch

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Gestational trophoblastic disease

    Michael J Seckl;Neil J Sebire;Ross S Berkowitz

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes.

    P J Smith;L S Wise;R Berkowitz;C Wan

  • Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer

    Jae Hoon Kim;Steven J. Skates;Toshimitsu Uede;Kwong Kwok Wong

  • Primary Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for Ovarian Cancer Risk Reduction

    Michael J. Callahan;Christopher P. Crum;Fabiola Medeiros;David W. Kindelberger

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Fluoxetine in posttraumatic stress disorder.

    B A van der Kolk;D Dreyfuss;M Michaels;D Shera

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Haptoglobin-α subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry

    Bin Ye;Daniel W. Cramer;Steven J. Skates;Steven P. Gygi

  • Prostasin, a Potential Serum Marker for Ovarian Cancer: Identification Through Microarray Technology

    Samuel C. Mok;Julie Chao;Steven Skates;Kwong Kwok Wong

  • Dissociative disorders in psychiatric inpatients.

    G. N. Saxe;B. A. van der Kolk;R. Berkowitz;G. Chinman

  • Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy

    Shannon M. McAuliffe;Stefanie L. Morgan;Gregory A. Wyant;Lieu T. Tran

  • Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy

    Joan Montero;Kristopher A. Sarosiek;Joseph D. DeAngelo;Ophélia Maertens

Frequent Co-Authors

Samuel C. Mok
Samuel C. Mok The University of Texas MD Anderson Cancer Center
Christopher P. Crum
Christopher P. Crum Brigham and Women's Hospital
Daniel W. Cramer
Daniel W. Cramer Brigham and Women's Hospital
Ursula A. Matulonis
Ursula A. Matulonis Harvard University
Michael J. Birrer
Michael J. Birrer University of Arkansas for Medical Sciences
Deborah J. Anderson
Deborah J. Anderson Boston University
Robert C. Bast
Robert C. Bast The University of Texas MD Anderson Cancer Center
Ellice Lieberman
Ellice Lieberman Brigham and Women's Hospital
Ronny Drapkin
Ronny Drapkin University of Pennsylvania
Matthew Meyerson
Matthew Meyerson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees can open diverse career opportunities for those interested in medicine but seeking flexible or specialized paths. Online programs now make it easier to advance your education while balancing work or personal commitments.

For nurses aiming to specialize in mental health, there are shortest post master's pmhnp online programs that quickly prepare you for advanced roles in psychiatric care. If you're interested in the business side of healthcare, a health care administration degree online provides foundational skills for management positions in hospitals or clinics.

Those seeking leadership roles often pursue graduate studies. You can find the cheapest online mha programs to earn your master's degree in healthcare administration without a large financial burden. Alternatively, nurses looking to achieve the highest level of clinical practice might consider the cheapest bsn to dnp programs.

These online degree pathways cater to a range of interests in the medical field, helping you build a rewarding career on your own schedule and at a manageable cost.

Best Scientists Citing Ross S. Berkowitz

Trending Scientists

Recently Published Articles